Indian equity markets extended their winning streak for a fourth consecutive session, buoyed by sustained inflows from foreign portfolio investors and a supportive macro backdrop of declining oil prices.
The broad-based rally lifted benchmark indices, with the Sensex and Nifty 50 advancing as buying interest persisted across key sectors.
These names came into focus due to a mix of regulatory updates, overseas expansion plans, project wins, and strategic initiatives reported ahead of Thursday's trading session.
Investors focused on a cluster of stocks including Dr Reddy's Laboratories, Sun Pharma, NBCC, GAIL, UPL, Tata Chemicals, and Hirect.
These names came into focus due to a mix of regulatory updates, overseas expansion plans, project wins, and strategic initiatives reported ahead of Thursday's trading session.
The concentration of positive catalysts across pharmaceuticals, infrastructure, and chemicals provided specific entry points for traders looking to capitalize on the broader market momentum.
The rally follows a period of steady accumulation by foreign funds, who have been net buyers in recent sessions.